Furthermore, the up-regulation of the microtubule-associated tumour suppressor gene Mtus2, shown to limit the metastatic activity of cancer cells (Kuo et al, 2017) and to express a long non-coding RNA Mtus2-5 playing a key role in the angiogenesis of patients with a multifactorial thrombosis condition (Zhang et al, 2023), might be of interest as a downstream target of oxaliplatin IV treatment. Here, MTUS2 is linked to Venous thrombosis.